Manipulation of inflammation modulates hyperlipidemia in apolipoprotein E-deficient mice: A possible role for interleukin-6
- 21 May 2006
- Vol. 34 (3-4) , 224-232
- https://doi.org/10.1016/j.cyto.2006.05.007
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Cytokines in Atherosclerosis: Pathogenic and Regulatory PathwaysPhysiological Reviews, 2006
- Turpentine-induced inflammation reduces the hepatic expression of the multiple drug resistance gene, the plasma cholesterol concentration and the development of atherosclerosis in apolipoprotein E deficient miceBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005
- Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary interventionThe American Journal of Cardiology, 2005
- Aspirin Attenuates the Initiation but Not the Progression of Atherosclerosis in Apolipoprotein E‐Deficient Mice Fed a High‐Fat, High‐Cholesterol DietBasic & Clinical Pharmacology & Toxicology, 2004
- Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor–null miceNature Medicine, 2003
- IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.Journal of Clinical Investigation, 1998
- Effects of Dexamethasone on the Synthesis, Degradation, and Secretion of Apolipoprotein B in Cultured Rat HepatocytesArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992
- Anti-inflammatory drugs in experimental atherosclerosis Part 1. Relative potencies for inhibiting plaque formationAtherosclerosis, 1973